In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
In the latest session, LifeStance Health Group Inc (NASDAQ: LFST) closed at $7.09 up 0.42% from its previous closing price of $7.06. In other words, the price has increased by $0.42 from its previous closing price. On the day, 0.73 million shares were traded. LFST stock price reached its highest trading level at $7.13 during the session, while it also had its lowest trading level at $7.0.
Ratios:
For a deeper understanding of LifeStance Health Group Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 13.53 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 23.10. For the most recent quarter (mrq), Quick Ratio is recorded 1.58 and its Current Ratio is at 1.58. In the meantime, Its Debt-to-Equity ratio is 0.32 whereas as Long-Term Debt/Eq ratio is at 0.28.
Upgrades & Downgrades
In the most recent recommendation for this company, Barclays on December 09, 2025, initiated with a Overweight rating and assigned the stock a target price of $8.
On November 13, 2025, BMO Capital Markets started tracking the stock assigning a Outperform rating and target price of $8.
On July 25, 2025, BTIG Research started tracking the stock assigning a Buy rating and target price of $8.BTIG Research initiated its Buy rating on July 25, 2025, with a $8 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Dec 19 ’25 when Bessler Robert sold 119,942 shares for $7.04 per share. The transaction valued at 844,392 led to the insider holds 1,318,983 shares of the business.
Bessler Robert sold 1,701 shares of LFST for $11,975 on Dec 22 ’25. The Director now owns 1,318,133 shares after completing the transaction at $7.04 per share. On Dec 22 ’25, another insider, Bessler Robert, who serves as the Director of the company, bought 1,701 shares for $7.04 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LFST now has a Market Capitalization of 2758012160 and an Enterprise Value of 3027750912. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.02 while its Price-to-Book (P/B) ratio in mrq is 1.85. Its current Enterprise Value per Revenue stands at 2.214 whereas that against EBITDA is 46.761.
Stock Price History:
The Beta on a monthly basis for LFST is 1.12, which has changed by -0.05340451 over the last 52 weeks, in comparison to a change of 0.16098404 over the same period for the S&P500. Over the past 52 weeks, LFST has reached a high of $8.30, while it has fallen to a 52-week low of $3.74. The 50-Day Moving Average of the stock is 16.58%, while the 200-Day Moving Average is calculated to be 24.61%.
Shares Statistics:
For the past three months, LFST has traded an average of 2.08M shares per day and 3188850 over the past ten days. A total of 389.00M shares are outstanding, with a floating share count of 160.11M. Insiders hold about 58.85% of the company’s shares, while institutions hold 40.27% stake in the company. Shares short for LFST as of 1765756800 were 8516750 with a Short Ratio of 4.10, compared to 1763078400 on 6377649. Therefore, it implies a Short% of Shares Outstanding of 8516750 and a Short% of Float of 9.86.
Earnings Estimates
The market rating for LifeStance Health Group Inc (LFST) is a result of the insights provided by 3.0 analysts actively involved in the assessment.The consensus estimate for the next quarter is $0.05, with high estimates of $0.05 and low estimates of $0.05.
Analysts are recommending an EPS of between $0.21 and $0.2 for the fiscal current year, implying an average EPS of $0.21. EPS for the following year is $0.25, with 3.0 analysts recommending between $0.27 and $0.23.
Revenue Estimates
A total of 8 analysts believe the company’s revenue will be $378.05M this quarter.It ranges from a high estimate of $383.57M to a low estimate of $374.3M. As of. The current estimate, LifeStance Health Group Inc’s year-ago sales were $325.5MFor the next quarter, 8 analysts are estimating revenue of $381.48M. There is a high estimate of $389.86M for the next quarter, whereas the lowest estimate is $369.93M.
A total of 9 analysts have provided revenue estimates for LFST’s current fiscal year. The highest revenue estimate was $1.43B, while the lowest revenue estimate was $1.42B, resulting in an average revenue estimate of $1.42B. In the same quarter a year ago, actual revenue was $1.25BBased on 9 analysts’ estimates, the company’s revenue will be $1.62B in the next fiscal year. The high estimate is $1.64B and the low estimate is $1.6B.
